Ensuring the Biologic Safety of Plasma-Derived Therapeutic Proteins

Arzneimittelforschung

2005 • 8,820 citations

Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome

1989 • 6,910 citations

Prions

1998 • 5,102 citations

Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome

2003 • 4,621 citations

A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

2003 • 4,443 citations

An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis

1989 • 3,401 citations

Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent

1997 • 1,951 citations

The Risk of Transfusion-Transmitted Viral Infections

1996 • 1,893 citations

Preparation and Properties of Serum and Plasma Proteins. IV. A System for the Separation into Fractions of the Protein and Lipoprotein Components of Biological Tissues and Fluids^1a,b,c,d

1946 • 1,815 citations

Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis

1989 • 1,698 citations

High Levels of HIV-1 in Plasma During All Stages of Infection Determined By Competitive PCR

1993 • 1,263 citations

Eight prion strains have PrPSc molecules with different conformations

1998 • 1,236 citations

Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding

2001 • 1,228 citations

Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion

2004 • 1,123 citations

VIRUS-LIKE PARTICLES IN SERUM OF PATIENTS WITH AUSTRALIA-ANTIGEN-ASSOCIATED HEPATITIS

1970 • 1,003 citations

Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient

2004 • 846 citations

Human spongiform encephalopathy: The national institutes of health series of 300 cases of experimentally transmitted disease

1994 • 813 citations

West Nile virus

2002 • 718 citations

Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans

1999 • 601 citations

Transmission of prion diseases by blood transfusion

2002 • 527 citations

Preclinical variant CJD after blood transfusion in a PRNP codon 129 heterozygous patient

2004 • 492 citations

NASBATM isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection

1991 • 413 citations

Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors

1995 • 375 citations

Creutzfeldt–Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study

2006 • 365 citations

Current and Emerging Infectious Risks of Blood Transfusions

2003 • 336 citations

The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy

1998 • 307 citations

Inactivation of Transmissible Degenerative Encephalopathy Agents: A Review

2000 • 298 citations

Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt‐Jakob disease in humans

1999 • 293 citations

Nucleic Acid Sequence-Based Amplification Assays for Rapid Detection of West Nile and St. Louis Encephalitis Viruses

2001 • 277 citations

Establishment of the First International Standard for Nucleic Acid Amplification Technology (NAT) Assays for HCV RNA

1999 • 270 citations

Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection

2003 • 263 citations

An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques

2001 • 254 citations

Immunopathogenesis of HIV Infection

2002 • 252 citations

Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets

2000 • 240 citations

Transfusion-associated bacterial sepsis

1994 • 225 citations

Nanofiltration of plasma‐derived biopharmaceutical products

2003 • 206 citations

Reducing the risk of infection from plasma products: specific preventative strategies

2000 • 195 citations

Detection of Australia Antigen and Antibody by Means of Radioimmunoassay Techniques

1970 • 179 citations

The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection

1997 • 171 citations

A cDNA fragment of hepatitis C virus isolated from an implicated donor of post-transfusion non-A, non-B hepatitis in Japan

1989 • 164 citations

Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein.

1991 • 156 citations

Creutzfeldt-Jakob disease in mice: persistent viremia and preferential replication of virus in low-density lymphocytes

1983 • 143 citations

Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein

2000 • 139 citations

The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1

1999 • 139 citations

Cost‐effectiveness of expanded human immunodeficiency virus‐testing protocols for donated blood

1997 • 135 citations

Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease

2001 • 135 citations

Prevalence of Human Immunodeficiency Virus Type 1 p24 Antigen in U.S. Blood Donors — An Assessment of the Efficacy of Testing in Donor Screening

1990 • 130 citations

HIV and the blood supply: an analysis of crisis decision making.

1996 • 128 citations

Antibody Response to Human Immunodeficiency Virus After Primary Infection

1987 • 127 citations

Inactivation of parvovirus B19 during pasteurization of human serum albumin

2002 • 126 citations

Establishment of the First International Standard for Nucleic Acid Amplification Technology (NAT) Assays for HCV RNA

1999 • 126 citations

Assay of Australia Antigen and Antibody Employing Double-Antibody and Solid-Phase Radioimmunoassay Techniques and Comparison with the Passive Hemagglutination Methods

1971 • 126 citations

Affinity chromatography in the industrial purification of plasma proteins for therapeutic use

2001 • 125 citations

Direct Detection of HIV-1 RNA from AIDS and ARC Patient Samples

1988 • 123 citations

Australia Antigen in Volunteer and Paid Blood Donors

1971 • 123 citations

Epidemiology of Creutzfeldt-Jakob disease

1993 • 120 citations

Highly Sensitive Multiplex Assay for Detection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus RNA

2002 • 117 citations

A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins

2001 • 115 citations

A novel erythroid-specific marker of transmissible spongiform encephalopathies

2001 • 115 citations

Further Studies on a "New" Human Isoprecipitin System (Australia Antigen)

1966 • 111 citations

Studies on the Removal of Abnormal Prion Protein by Processes Used in the Manufacture of Human Plasma Products

2000 • 108 citations

Screening of Selected Male Blood Donors for p24 Antigen of Human Immunodeficiency Virus Type 1

1990 • 104 citations

Parvovirus B19 transmission by heat‐treated clotting factor concentrates

2002 • 103 citations

Studies on the Removal of Abnormal Prion Protein by Processes Used in the Manufacture of Human Plasma Products

2000 • 98 citations

An international collaborative study to establish the 1st international standard for HIV-1 RNA for use in nucleic acid-based techniques

2001 • 98 citations

Enveloped Virus Inactivation by Caprylate: A Robust Alternative to Solvent-Detergent Treatment in Plasma Derived Intermediates

2002 • 98 citations

Improved conformation-dependent immunoassay: suitability for human prion detection with enhanced sensitivity

2003 • 97 citations

Properties of a new intravenous immunoglobulin (IGIV‐C, 10%) produced by virus inactivation with caprylate and column chromatography

2003 • 97 citations

Establishment of the first World Health Organization International Standard for human parvovirus B19 DNA nucleic acid amplification techniques

2002 • 93 citations

Surveillance for Creutzfeldt‐Jakob disease among persons with hemophilia

1998 • 83 citations

Scrapie Infectivity in Hamster Blood Is Not Associated with Platelets

2002 • 79 citations

Life‐threatening human parvovirus B19 infection transmitted by intravenous immune globulin

2002 • 76 citations

Scrapie Removal using Planova®Virus Removal Filters

2001 • 76 citations

Prion Protein and the Transmissible Spongiform Encephalopathy Diseases

1999 • 75 citations

Calibration of HCV Working Reagents for NAT Assays against the HCV International Standard

2000 • 74 citations

Identification of Scrapie Infection from Blood Serum by Fourier Transform Infrared Spectroscopy

2002 • 74 citations

Australia Antigen: Distribution during Cohn Ethanol Fractionation of Human Plasma

1970 • 68 citations

Evaluation of virus and prion reduction in a new intravenous immunoglobulin manufacturing process

2003 • 68 citations

Calibration of HCV Working Reagents for NAT Assays against the HCV International Standard

2000 • 66 citations

THE TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES

1995 • 65 citations

Partitioning of human and sheep forms of the pathogenic prion protein during the purification of therapeutic proteins from human plasma

2002 • 62 citations

VIRUS-LIKE PARTICLES IN SERUM OF PATIENTS WITH AUSTRALIA-ANTIGEN-ASSOCIATED HEPATITIS

1970 • 62 citations

Inactivation of Lipid‐Enveloped Viruses in Proteins by Caprylate

1991 • 59 citations

Retrospective Neuropathological Review of Prion Disease in UK Haemophilic Patients

1998 • 59 citations

Low risk of viral infection after administration of vapor‐heated factor VIII concentrate

1992 • 57 citations

Inactivation of Lipid Enveloped Viruses by Octanoic Acid Treatment of Immunoglobulin Solution

2002 • 57 citations

Performance of three generations of anti‐hepatitis C virus enzyme‐ linked immunosorbent assays in donors and patients

1997 • 56 citations

Epidemiology of Creutzfeldt-Jakob Disease in the United States, 1979–1990: Analysis of National Mortality Data

1995 • 53 citations

Hepatitis C virus: Quantitation and distribution in liver

1997 • 52 citations

Determination of Adequate Moisture Content for Efficient Dry-Heat Viral Inactivation in Lyophilized Factor VIII by Loss on Drying and by Near Infrared Spectroscopy

1998 • 51 citations

Purity of Spiking Agent Affects Partitioning of Prions in Plasma Protein Purification

2002 • 50 citations

Effectiveness of alternative treatments for reducing potential viral contaminants from plasma-derived products

2002 • 48 citations

Detection of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in Pools of Sera Negative for Antibodies to HIV-1 and HIV-2

1998 • 44 citations

Inactivation of Lipid‐Enveloped Viruses in Labile Blood Derivatives by Unsaturated Fatty Acids

1988 • 42 citations

Organ distribution of prion proteins in variant Creutzfeldt-Jakob disease

2003 • 41 citations

Peripheral pathogenesis of prion diseases

2000 • 39 citations

Solvent-dependent precipitation of prion protein

2002 • 33 citations

Diagnostic value of the strand displacement amplification method compared to those of Roche Amplicor PCR and culture for detecting mycobacteria in sputum samples

1997 • 32 citations

Calibration of HIV-1 working reagents for nucleic acid amplification techniques against the 1st international standard for HIV-1 RNA

2003 • 31 citations

Inactivation of hepatitis A virus in plasma products by vapor heating

1997 • 29 citations

Preparation of Human Immunoglobulin by Caprylic Acid Precipitation

1984 • 29 citations

Application of Nucleic Acid Amplification Techniques for Blood Donation Screening

1998 • 29 citations

Prion diseases

1998 • 28 citations

[Properties and efficacy of a human immunoglobulin M preparation for intravenous administration].

1985 • 28 citations

Stabilization of Serum Albumin to Heat, and Inactivation of the Hepatitis Virus

1984 • 28 citations

Detection of HCV RNA by the asymmetric gap ligase chain reaction.

1994 • 27 citations

A World Health Organization International Standard for hepatitis A virus RNA nucleic acid amplification technology assays

2005 • 24 citations

PRESENCE AND PERSISTENCE OF AUSTRALIAN ANTIGEN IN A SWEDISH HEPATITIS SERIES

1969 • 24 citations

Clinical spectrum of human retroviral-induced diseases.

1985 • 21 citations

[Isolation of IgG immunoglobulin from human plasma using caprylic acid].

1969 • 19 citations

International Standardization of Gene Amplification Technology

1998 • 16 citations

Practical applications of TCM

2002 • 15 citations

A novel erythroid-specific marker of transmissible spongiform encephalopathiesG. Miele, J. Manson, M. Clinton. Nat Med 7:361–364, 2001

2001 • 11 citations

Prevalance of hepatitis C virus in plasma pools and the effectiveness of cold ethanol fractionation

1996 • 11 citations

Retrospective neuropathological review of prion disease in UK haemophilic patientsLee CA, Ironside JW, Bell JE, et al. Thromb Haemost 80:909–911, 1998

1999 • 11 citations

Viral inactivation vs biological activity.

1993 • 8 citations

Viral safety of coagulation factor concentrates.

1993 • 7 citations

Efficacy of viral clearance methods used in the manufacture of activated prothrombin complex concentrates: focus on AUTOPLEX® T

1999 • 7 citations

Variation in the sensitivity of HBsAg screening kits

1996 • 6 citations

Good manufacturing practice (GMP) compliance in the biologics sector: plasma fractionation

1999 • 5 citations

Australia Antigen in Various Plasma Fractions

1970 • 4 citations

Practical Applications of the Australia Antigen Test

1971 • 4 citations

Report on the WHO Collaborative Study to Establish an International Standard for HAV RNA Nucleic Acid Amplification Technology (NAT) Assays

2003 • 1 citations